NBIA2A is a subtype of neurodegeneration with brain iron accumulation (FBhh0000223). It is one of several diseases associated with the human gene PLA2G6. See the human disease model report for neurodegenerative disease, PLA2G6-related (FBhh0000243).
[updated Apr. 2016 by FlyBase; FBrf0222196]
Neurodegeneration with brain iron accumulation (NBIA) is a genetically heterogeneous disorder characterized by progressive iron accumulation in the basal ganglia and other regions of the brain, resulting in extrapyramidal movements, such as parkinsonism and dystonia. Age at onset, severity, and cognitive involvement are variable (review by Gregory et al., 2009; pubmed:18981035). [from MIM:234200; 2016.03.29]
[NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A; NBIA2A](https://omim.org/entry/256600)
[PHOSPHOLIPASE A2, GROUP VI; PLA2G6](https://omim.org/entry/603604)
See general description above. Neurodegeneration with brain iron accumulation 2A (NBIA2A) is characterized by onset in the first 2 years of life. NBIA2A exhibits earlier onset and a more homogeneous phenotype than NBIA2B (MIM:610217). [from MIM:256600, MIM:610217; 2016.04.05]
NBIA2A is caused by homozygous or compound heterozygous mutation in the PLA2G6 gene (phospholipase A2, group VI). [from MIM:256600; 2016.04.05]